Institutional Fund
Diadema Partners LP
Morristown, NJCIK 20261725 filings on record
Portfolio Value
$242.18M
Q1 2026
Holdings
86
Reported positions
New Buys
44
Opened this quarter
QoQ Change
+44.2%
from $167.91M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Bridgebio Pharma Inc7.7%
- Viking Therapeutics Inc7.1%
- United Therapeutics Corp Del6.7%
- Johnson & Johnson5.4%
- Cogent Biosciences Inc5.1%
- Jazz Pharmaceuticals PLC4.3%
- Other63.8%
Portfolio Holdings
86 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Bridgebio Pharma Inc | 250.0K | $18.57M | 7.7% | +250.0K | New |
| 2 | Viking Therapeutics Inc | 525.2K | $17.09M | 7.1% | +188.3K | Added |
| 3 | United Therapeutics Corp Del | 27.3K | $16.19M | 6.7% | +17.3K | Added |
| 4 | Johnson & Johnson | 53.8K | $13.14M | 5.4% | −12.7K | Reduced |
| 5 | Cogent Biosciences Inc | 322.8K | $12.42M | 5.1% | +190.9K | Added |
| 6 | Jazz Pharmaceuticals PLC | 54.8K | $10.35M | 4.3% | +54.8K | New |
| 7 | Terns Pharmaceuticals Inc | 181.8K | $9.58M | 4.0% | −164.1K | Reduced |
| 8 | Biomarin Pharmaceutical Inc | 148.2K | $8.37M | 3.5% | +1.9K | Added |
| 9 | Abivax SA | 75.9K | $8.22M | 3.4% | +300 | Added |
| 10 | Revolution Medicines Inc | 80.9K | $7.86M | 3.2% | +43.9K | Added |
76 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio